SEP 29, 2016 8:00 AM PDT

Magnetic 3D Bioprinting of Cells: Overcoming Imaging Obstacles in Spheroids

Sponsored by: Cytiva
Speaker
  • President and CSO at Nano3D Biosciences, Inc. and Adjunct Assistant Professor at University of Texas Health Science Center at Houston
    Biography
      Dr. Glauco R. Souza is the President, CSO, and co-founder of Nano3D Biosciences, Inc. (n3D). He is one of the co-inventors and inventor of all patents related to n3D's 3D cell culturing by magnetic levitation and magnetic 3D bioprinting technologies. Dr. Souza is also Adjunct Assistant Professor at University of Texas Health Science Center at Houston. Prior to co-founding n3D, Dr. Souza was an Odyssey Scholar at UT MD Anderson Cancer Center. During his work at MD Anderson, he applied a multidisciplinary approach to developing nanotechnology tools for tissue targeted imaging, gene delivery, and tissue engineering. Towards the end of his post-doctoral tenure at MD Anderson, in collaboration with Rice University, the genesis of 3D cell culturing by magnetic levitation and magnetic 3D bioprinting took place. Results using these groundbreaking technologies have been reported in various high-impact scientific journals, including Nature Nanotechnology, Nature Protocols, and Nature Reviews Cancer. Now, Dr. Souza's research mission is as CSO of n3D is to advance 3D cell culturing by magnetic levitation and magnetic 3D bioprinting into a routine laboratory tool that will measurably improve the drug discovery process, cancer research, and regenerative medicine. Recently, Glauco was an invited speaker at TEDx Houston, where he shared his thoughts and experience on resonating aspects between science, levitating cells, friendship, and sports as key ingredients for scientific discovery and the entrepreneurial process. Dr. Souza's research has been funded by grants from National Science Foundation (NSF), National Institute of Health (NIH), Department of Defense (DOD), Center for Advancement of Science in Space (CASIS), and Texas Emerging Technology Fund (ETF).

    Abstract

    PRESENTED BY:



    DATE:
     September 29, 2016
    TIME:  8:00AM PT, 11AM ET

    Interest in 3D cell culture has grown exponentially in recent years, partially due to 3D cultures helping to overcome the challenges of using animal models and inadequacy of 2D cultures.  Challenges are still present because of the physical nature of 3D cultures, especially when using confocal microscopy for visualization as result of limited light penetration through 3D structures. To overcome these limitations, Nano3D Biosciences and  MD Anderson together have  developed methods and protocols using magnetic 3D bioprinting techniques to successfully overcome such challenges.  The results have helped to identify novel approaches to study biology using 3D cell culture and automated confocal imaging of spheroids.
     
    Attendees will learn:
                    -Magnetic 3D bioprinting of spheroids and rings
                    -Tips for high-throughput confocal imaging of 3D cells
                    -Techniques for bioprinting cell co-cultures
                    -Rapid 3D model formation with easy post culture analysis


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    Loading Comments...
    Show Resources